3386 — Cosmo Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥6bn
- ¥4bn
- ¥9bn
- 76
- 78
- 47
- 80
Annual cashflow statement for Cosmo Bio Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 388 | 1,008 | 1,099 | 790 | 653 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 25 | -244 | -57 | -50 | -98 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -71 | -136 | -560 | -596 | 33 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 549 | 803 | 648 | 285 | 736 |
| Capital Expenditures | -182 | -65 | -141 | -104 | -100 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 67 | 107 | -4 | -187 | -658 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -115 | 42 | -145 | -291 | -758 |
| Financing Cash Flow Items | -3 | -3 | -3 | -4 | -4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -85 | -97 | -420 | -236 | -201 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 348 | 743 | 95 | -218 | -210 |